Article
Association of Serotonin Transporter Gene 5HTTLPR rs25531 Polymorphism With Escitalopram Efficacy in Patients With Major Depressive Disorder.
Pharmacotherapy - 1 Feb 2026
Afridi Muhammad Faisal, Zakki Shahbaz Ahmad, Rafiullah Rafiullah, Haq Ijaz Ul
Abstract excerpt
BACKGROUND: Escitalopram is considered a cornerstone therapy for major depression, but inter-individual variations exist in its clinical efficacy. The current study aims to explore the possible association between serotonin transporter gene (SLC6A4) polymorphism 5HTTLPR-rs25531 and clinical efficacy of escitalopram in a Pakistani population suffering from major depressive disorder. METHODOLOGY: This prospective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
